Medicare AdvantageCoverageMedium impact
MA11.002o, Hematopoietic Stem Cell Transplantation
Independence Blue Cross·Oncology, Hematology·Medical Policy
Effective date
Jul 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.002o regarding Hematopoietic Stem Cell Transplantation has been updated with changes effective July 1, 2025. This policy covers stem cell transplant procedures and related services, though specific details require reviewing the full policy document.
Action Required
By July 1, 2025: Billing team must review the complete updated policy MA11.002o for Hematopoietic Stem Cell Transplantation at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or billing procedures for Medicare Advantage plans. Update billing workflows and staff training accordingly based on the full policy details.